Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York.
Respiratory Care Program, School of Health Technology and Management, Stony Brook University, Stony Brook, New York.
Respir Care. 2022 Aug;67(8):914-928. doi: 10.4187/respcare.09459. Epub 2022 May 31.
Recent observational studies of nebulizers placed on the wet side of the humidifier suggest that, after some time, considerable condensation can form, which triggers an occlusion alarm. In the current study, an inline breath-enhanced jet nebulizer was tested and compared in vitro with a vibrating mesh nebulizer on the humidifier dry-inlet side of the ventilator circuit.
Two duty cycle breathing patterns were tested during continuous infusion (5 or 10 mL/h) with and without dynamic changes in infusion flow and duty cycle, or bolus delivery (3 or 6 mL) of radiolabeled saline solution. Inhaled mass (IM) was measured by a real-time ratemeter (µCi/min) and analyzed by multiple linear regression.
During simple continuous infusion, IM increased linearly for both nebulizer types. IM variability was attributable to the duty cycle ( < .001) (34%) and infusion flow ( < .001) (32%) but independent of nebulizer technology ( = .38) (7%). Dynamic continuous infusion studies that simulate clinical scenarios with ventilator and pump flow changes demonstrated a linear increase in the rate of aerosol that was dependent on pump flow ( < .001) (63%) and minimally dependent on the duty cycle ( = .003) (8%). During bolus treatments, IM increased linearly to plateau. IM variability was attributable to the duty cycle ( < .001) (40%) and residual radioactivity in the nebulizer ( < .001) (20%). Separate analysis revealed that the vibrating mesh nebulizer residual volume contributed 16% of the variability and inline breath-enhanced jet nebulizer contributed 5%. IM variability was independent of bolus volume ( = .82) (1%). System losses were similar (the inline breath-enhanced jet nebulizer: 32% residual in nebulizer; the vibrating mesh nebulizer: 34% in circuitry).
Aerosol delivery during continuous infusion and bolus delivery was comparable between the inline breath-enhanced jet nebulizer and the vibrating mesh nebulizer, and was determined by pump flow and initial ventilator settings. Further adjustments in ventilator settings did not significantly affect drug delivery. Expiratory losses predicted by the duty cycle were reduced with placement of the nebulizer near the ventilator outlet.
最近对湿化器湿侧放置的喷雾器进行的观察性研究表明,经过一段时间后,会形成相当大的冷凝水,从而触发阻塞警报。在本研究中,对在线呼吸增强射流喷雾器进行了测试,并与呼吸机回路湿侧进气口处的振动网式喷雾器进行了体外比较。
在连续输注(5 或 10 mL/h)过程中,测试了两种工作周期呼吸模式,输注流量和工作周期是否有动态变化,或给予放射性标记盐水溶液的推注(3 或 6 mL)。通过实时速率计(µCi/min)测量吸入质量(IM),并通过多元线性回归进行分析。
在简单的连续输注过程中,两种喷雾器类型的 IM 均呈线性增加。IM 的可变性归因于工作周期(<0.001)(34%)和输注流量(<0.001)(32%),但与喷雾器技术无关(=0.38)(7%)。模拟呼吸机和泵流量变化的临床情况的动态连续输注研究表明,气溶胶的产生率呈线性增加,这取决于泵流量(<0.001)(63%),且最小程度上取决于工作周期(=0.003)(8%)。在推注治疗期间,IM 呈线性增加至平台期。IM 的可变性归因于工作周期(<0.001)(40%)和喷雾器中残留的放射性(<0.001)(20%)。单独分析表明,振动网式喷雾器的残留体积占可变性的 16%,在线呼吸增强射流喷雾器占 5%。IM 的可变性与推注体积无关(=0.82)(1%)。系统损失相似(在线呼吸增强射流喷雾器:喷雾器中残留 32%;振动网式喷雾器:电路中残留 34%)。
在连续输注和推注过程中,在线呼吸增强射流喷雾器和振动网式喷雾器的气溶胶输送情况相当,这取决于泵流量和初始呼吸机设置。进一步调整呼吸机设置不会显著影响药物输送。通过将喷雾器放置在靠近呼吸机出口处,可减少预测的工作周期呼气损失。